NC009-1 has been shown previously to have aggregation-reducing and neuroprotection effects by activating HSPB1 to increase pro-aggregated ΔK280 TauRD solubility and promote neurite outgrowth in tauopathy cell model [32]. This evidence concerns the gene HSPB1 and tauopathy.